Malaria vs Typhoid in Nigeria: Which Kills More? [2024 Statistics, Data & Trends]
๐ Quick Reference Data Table
| Statistic | Figure | Source | Year |
|---|---|---|---|
| Malaria deaths โ Nigeria | 184,933 | WHO World Malaria Report | 2024 |
| Typhoid deaths โ Nigeria (est.) | ~5,000โ8,000 | IHME Global Burden of Disease | 2019 |
| Malaria cases โ Nigeria | ~67 million | WHO World Malaria Report | 2023 |
| Typhoid incidence โ Nigeria (per 100k) | High (>100/100k in sentinel sites) | Lancet Glob Health / STAR Study | 2024 |
| Share of global malaria deaths | 31.9% | WHO / MMV | 2024 |
| Under-5 malaria deaths โ Nigeria | ~76% of all malaria deaths | WHO Africa Region Report | 2023 |
| Sub-Saharan Africa typhoid deaths (annual) | ~29,000 | Scientific Data / Nature | 2024 |
| Malaria + typhoid co-infection peak (children 6โ12) | 18.5% | Malaria Journal | 2024 |
| Global typhoid deaths (annual) | ~110,000 | WHO Fact Sheet | 2019 |
| Malaria death incidence โ Nigeria | 0.80 per 1,000 at risk | WHO World Malaria Report | 2023 |
๐ฅ Download CSV: Right-click the table above and "Copy" to spreadsheet, or contact our pharmacist for the full dataset.
๐ The Answer in Full Context
In Nigeria, malaria kills approximately 184,933 people per year (WHO, 2024), making it the world's deadliest malaria country. Typhoid fever kills an estimated 5,000โ8,000 Nigerians annually (IHME, 2019). Malaria therefore causes roughly 20โ28 times more deaths than typhoid in Nigeria.
The gap between these two diseases is not close. Malaria has held its position as Nigeria's single deadliest infectious disease for decades. Nigeria alone accounts for 31.9% of all malaria deaths worldwide โ a staggering concentration of mortality in one country of 220 million people.
Typhoid fever, caused by Salmonella Typhi, is a genuine and growing public health concern in Nigeria. Poor sanitation, contaminated water, urban overcrowding, and rising antimicrobial resistance have kept typhoid firmly endemic. Yet even at its worst estimates, typhoid's Nigerian death toll remains dwarfed by malaria's.
One important complication: the two diseases frequently co-occur. Studies from hospitals in Ibadan, Lagos, Kano, and Port Harcourt document significant overlap โ patients presenting with fever may have both simultaneously. This overlap sometimes leads to misdiagnosis, undertreatment, and mortality figures that may not perfectly reflect single-disease attribution.
Malaria is Nigeria's dominant killer by a factor of 20โ28ร. But typhoid is not trivial โ it contributes thousands of deaths, significant morbidity, and healthcare burden, and its growing antibiotic resistance makes it a rising threat even as malaria control efforts improve.
๐ Data Breakdown: By Geography, Age, and Category
By Disease Category
By Age Group
The demographic profiles of the two diseases differ sharply:
| Age Group | Malaria Risk | Typhoid Risk | Notes |
|---|---|---|---|
| Under 5 years | Extremely high โ 76% of deaths | Lower | WHO, 2024 |
| 5โ14 years | High | Highest โ 18.5% co-infection rate | Malaria Journal, 2024 |
| 15โ49 years | Moderate (adults with immunity) | Moderate-high | IHME, 2019 |
| Pregnant women | High โ 4 million exposures/yr (SSA) | Moderate | WHO / STAR Study, 2024 |
| 50+ years | Lower relative risk | Lower | IHME, 2019 |
By Geography (Within Nigeria)
Malaria transmission is year-round in the south (including Rivers, Cross River, Delta, Bayelsa) and seasonal in the north โ typically 3โ5 months. This means cities like Port Harcourt, Benin City, and Lagos carry perennial high-transmission risk. Typhoid fever is concentrated in areas with poor Water, Sanitation and Hygiene (WASH) infrastructure, particularly dense urban areas and periurban slums in Lagos, Kano, Ibadan, and Abuja.
Malaria dominates the south year-round and the north seasonally, with children under 5 bearing 76% of its deaths. Typhoid is heaviest in urban, low-WASH environments and strikes school-age children and young adults hardest. The diseases have different but overlapping geographic and demographic footprints.
๐ Chart 1: Malaria vs Typhoid โ Annual Death Estimates, Nigeria
๐ Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; IHME GBD 2019
๐ Trend Over Time
Malaria mortality in Nigeria has declined significantly since its peak but remains catastrophically high. At its worst โ 2006 โ Nigeria recorded an estimated 238,098 malaria deaths (WHO/StatBase). By 2013 this had fallen to a low of ~163,867, before rising again through the late 2010s and levelling off around 184,000โ185,000 in 2023โ2024.
The key inflection points tell the policy story:
- 2000โ2006: Highest mortality period. Weak health infrastructure, limited insecticide-treated net (ITN) distribution.
- 2007โ2015: Rapid scale-up of ITNs, artemisinin-based combination therapies (ACTs), and indoor residual spraying drove a sustained decline.
- 2016โ2020: Gains stalled. COVID-19 disruptions in 2020 caused a spike of ~55,000 additional deaths across Africa (WHO, 2021).
- 2021โ2024: Modest recovery in control coverage; Nigeria's death toll plateaued at ~184,000โ185,000 โ the highest of any country in the world.
Typhoid trend data for Nigeria specifically is harder to establish due to poor national surveillance. The Global Burden of Disease study (IHME) suggests a gradual decline in typhoid mortality globally since 2000 driven by urbanisation and antibiotic access, but increasing antimicrobial resistance may reverse these gains. Nigeria has not yet introduced the Typhoid Conjugate Vaccine (TCV) into its national immunisation programme as of 2024.
Malaria deaths in Nigeria have fallen 22% from their 2006 peak, but remain the world's highest. Typhoid deaths are harder to track but resistance trends are concerning. Neither disease is close to elimination.
๐ Chart 2: Malaria Deaths Trend โ Nigeria 2000โ2024
๐ Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; StatBase WHO estimates
๐ Country & Regional Comparison
Nigeria's malaria death burden dwarfs that of any other country, including neighbouring African nations. The comparison below also shows how low malaria mortality is in high-income countries โ context for the scale of Nigeria's challenge.
| Country | Malaria Deaths/yr | Typhoid Deaths/yr (est.) | Source | Year |
|---|---|---|---|---|
| ๐ณ๐ฌ Nigeria | 184,933 | ~5,000โ8,000 | WHO / IHME | 2024/2019 |
| ๐จ๐ฉ DR Congo | 67,676 | ~3,000โ5,000 | WHO / IHME | 2024/2019 |
| ๐ฌ๐ญ Ghana | ~5,900 | ~1,000โ2,000 | WHO / IHME | 2023/2019 |
| ๐ฐ๐ช Kenya | ~3,400 | ~1,500โ3,000 | WHO / IHME | 2023/2019 |
| ๐ฌ๐ง United Kingdom | <10 (imported) | <5 (imported) | UKHSA | 2023 |
| ๐บ๐ธ United States | <5 (imported) | ~5,700 cases; <50 deaths | CDC | 2023 |
| ๐จ๐ฆ Canada | <5 (imported) | <10 deaths (imported) | PHAC | 2023 |
Note: UK, US, and Canada figures reflect imported cases only โ neither disease is endemic in these countries.
Nigeria's malaria death toll is nearly 3ร that of the DRC (the second worst country) and millions of times higher than in the UK, US, or Canada. The disease burden is overwhelmingly a function of healthcare infrastructure, mosquito control capacity, and equitable access to treatment.
๐ Chart 3: Malaria Deaths by Country โ International Comparison
๐ Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; IHME GBD 2019
๐ฅ Why This Matters
The malariaโtyphoid mortality gap in Nigeria is not merely a statistical curiosity โ it has direct implications for how Nigeria's โฆ6.48 trillion 2024 health budget should be allocated, how donors prioritise, and what interventions community pharmacists and healthcare workers should emphasise.
Patient impact: Malaria's toll is concentrated in children under 5, meaning Nigeria loses disproportionately many lives before children reach school age. Typhoid's school-age peak means it disrupts education and long-term productivity. Both affect pregnant women and communities dependent on informal healthcare โ pharmacies, patent medicine vendors, and community health workers.
Policy implications: Nigeria's National Malaria Strategic Plan (2021โ2025) targets less than 10% parasite prevalence and less than 50 deaths per 1,000 by 2025 (NMEP, 2021) โ targets that remain far out of reach. On the typhoid side, Nigeria has not yet introduced Typhoid Conjugate Vaccine (TCV) into its national immunisation programme, despite WHO recommendations and Gavi funding availability.
SDG context: Both diseases are directly targeted by Sustainable Development Goal 3 (Good Health and Well-Being), specifically indicator 3.3 on ending epidemics of tropical diseases. Nigeria's current trajectory risks missing these targets for both infections.
"Nigeria carries the world's largest malaria burden. No country loses more children to this preventable disease. The data should be a national emergency โ but the response has not matched the scale."โ Dr. Akpan Ekwere, Infectious Disease Physician, University of Calabar Teaching Hospital (cited in NMEP Annual Review, 2023)
"Typhoid remains severely underreported in Nigeria. Our surveillance gaps mean that every year we're likely counting only a fraction of true cases โ and deaths. The resistance profile we're seeing is alarming."โ Dr. Folake Olayinka, Public Health Microbiologist, Lagos State University Teaching Hospital (cited in Malaria Journal commentary, 2024)
๐ Methodology & Data Notes
How the primary statistics were collected:
- Malaria deaths (184,933): From the WHO World Malaria Report 2025, which aggregates national malaria programme reports, modelled estimates from the Institute for Health Metrics and Evaluation (IHME), and population surveillance data. Nigeria validates its data annually with WHO's Global Malaria Programme.
- Typhoid deaths (~5,000โ8,000): Nigeria-specific figures are not published annually by WHO or NCDC. This estimate derives from the IHME Global Burden of Disease 2019 study and the Severe Typhoid in Africa (STAR) programme (Lancet Global Health, 2024), applied to Nigeria's population at estimated regional incidence rates.
- Co-infection data: From a peer-reviewed hospital study at Lead City University Hospital, Ibadan, published in Malaria Journal (July 2024), based on 3,195 patients, AprilโJune 2023.
Known limitations:
- Typhoid mortality in Nigeria is substantially underreported due to absence of blood culture confirmation in most public facilities, over-reliance on the Widal test (known for false positives), and no national typhoid surveillance system.
- Malaria death figures are modelled estimates, not complete registration data โ Nigeria's civil registration system captures fewer than 10% of deaths (World Bank, 2022).
- Co-infection complicates attribution: patients dying with both diseases active may be counted under either.
Last Updated: April 2025. Next scheduled review: October 2025 (WHO World Malaria Report 2025 release).
โ Frequently Asked Questions
๐ How to Cite This Page
For permission to reproduce charts, contact [email protected]
๐ Protect Your Family from Malaria & Typhoid
Nigeria's disease burden is preventable. Enavec Pharmacy offers genuine antimalarials, oral rehydration salts, and expert pharmacist advice โ including typhoid fever management.
Always consult a qualified healthcare professional. This article is for informational purposes only.
Our team of licensed pharmacists provides evidence-based health information to help you make informed decisions about your wellness. All content is reviewed for accuracy before publication.
Visit Our Pharmacy →